Startseite Evaluation of the ABX Pentra 400: a newly available clinical chemistry analyser
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Evaluation of the ABX Pentra 400: a newly available clinical chemistry analyser

  • Pascal Coudène , Benjamin Marson , Stéphanie Badiou , Sébastien Flavier , Sébastien Anelli , Jean Paul Cristol und Anne Marie Dupuy
Veröffentlicht/Copyright: 21. September 2011
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

The performance of the ABX Pentra 400, a new multiparametric analyser available for routine and specialised clinical chemistry analyses, was evaluated according to the National Committee for Clinical Laboratory Standards (NCCLS) and Valtec protocols. Substrate concentrations and enzyme activities were determined by spectrophotometric measurement after coloured reaction or UV detection-based reactions; electrolyte concentrations were determined with ion-selective electrodes, and specific protein concentrations were assayed by immunoturbidimetry. In total, 32 of the most common clinical chemistry parameters were evaluated under simulated routine conditions. The analytical performance of the system and the quality of the ABX Pentra reagent line were both examined in a single-site study. The ABX Pentra 400 was compared with the Olympus AU640, Konelab-Konepro, Beckman Coulter-Immage and Beckman Coulter-Access 2, depending on the tests available on these analysers. The coefficient of variation (CV) values were within expected values. Coefficients of correlation showed high correlation between the analysers compared. The influence of interfering substances was moderate. The practicability of the system was good. We conclude that good reliability and practicability make the ABX Pentra 400 system suitable for laboratories with various needs.


Corresponding author: Anne Marie Dupuy, Department of Biochemistry, Lapeyronie Hospital, 34295 Montpellier, France

References

1. Vassault A, Grafmeyer D, Naudin C, Dumont G, Bailly M, Henny J, et al. Protocole de validation de techniques. Ann Biol Clin 1986; 44: 686–745. Suche in Google Scholar

2. Doumas BT, Kwok-Cheung PP, Perry BW, Jendrzejczak B, McComb RB, Schaffer R, Hause LL. Candidate reference method for determination of total bilirubin in serum: development and validation. Clin Chem 1985; 31: 1779–89. 10.1093/clinchem/31.11.1779Suche in Google Scholar

3. Rauscher et al. In: Berichte der Österreichischen Gesellschaft für Klinische Chemie 1998;14:150. Suche in Google Scholar

4. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Medl Res 1999; 8: 135–60. 10.1177/096228029900800204Suche in Google Scholar PubMed

5. Hollis S. Analysis of method comparison studies. Ann Clin Biochem 1996; 33: 1–4. 10.1177/000456329603300101Suche in Google Scholar PubMed

6. Wiener K. Blood sample tubes for lactate assay. Clin Chem 1995; 41: 483. 10.1093/clinchem/41.3.483aSuche in Google Scholar

7. Andersen O, Haugaard SB, Jorgensen LT, Sorensen S, Nielsen JO. Preanalytical handling of samples for measurement of plasma lactate in HIV patients. Scand J Clin Lab Invest 2003; 63: 449–54. 10.1080/00365510310005128Suche in Google Scholar PubMed

8. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38: 1933–53. 10.1093/clinchem/38.10.1933Suche in Google Scholar

9. Badiou S, Dupuy AM, Descomps B, Cristol JP. Comparison between the enzymatic Vitros assay for creatinine determination and three other methods adapted on the Olympus analyzer. J Clin Lab Anal 2003; 17: 235–40. 10.1002/jcla.10103Suche in Google Scholar PubMed PubMed Central

10. Giampietro O, Pilo A, Buzzigoli G, Boni C, Navalesi R. Four methods for glucose assay compared for various glucose concentrations and under different clinical conditions. Clin Chem 1982; 28: 2405–7. 10.1093/clinchem/28.12.2405Suche in Google Scholar

11. Brackeen GL, Dover JS, Long CL. Serum albumin. Differences in assay specificity. Nutr Clin Pract 1989; 4: 203–5. 10.1177/0115426589004006203Suche in Google Scholar PubMed

12. Warnick GR, Knopp RH, Fitzpatrick V, Branson L. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem 1990; 36: 15–9. 10.1093/clinchem/36.1.15Suche in Google Scholar

13. McNamara JR, Cohn JS, Wilson PW, Schaefer EJ. Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. Clin Chem 1990; 36: 36–42. 10.1093/clinchem/36.1.36Suche in Google Scholar

Received: 2005-1-4
Accepted: 2005-4-18
Published Online: 2011-9-21
Published in Print: 2005-7-1

©2005 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Inter-individual variation of inflammatory markers of cardiovascular risks and diseases
  2. “Coelionomics”: towards understanding the molecular pathology of coeliac disease
  3. Gene expression profiling in human cardiovascular disease
  4. A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio
  5. A quantitative RT-PCR method to determine topoisomerase I mRNA levels in human tissue samples
  6. Insulin sensitivity and counter-regulatory hormones in hypothyroidism and during thyroid hormone replacement therapy
  7. Linearity and detection limit in the measurement of serum M-protein with the capillary zone electrophoresis system Capillarys ®
  8. Quantitative measurement of ketone bodies in urine using reflectometry
  9. Quantification of voriconazole in plasma by liquid chromatography-tandem mass spectrometry
  10. Determination of the antioxidant capacity in blood
  11. High-workload endurance training may increase serum ischemia-modified albumin concentrations
  12. Advanced oxidation protein products in serum of patients with myotonic disease type I: association with serum γ-glutamyltransferase and disease severity
  13. Effectiveness of different methods for anti-Sm antibody identification. A multicentre study
  14. Quality control in neutrophil granulocyte (PMN) concentrates by flow cytometry
  15. Circadian variation of holo-transcobalamin (holo-TC) and related markers
  16. Elevated levels of plasma homocysteine in postmenopausal women in Burkina Faso
  17. Allergy testing on the IMMULITE 2000 Random-Access immunoanalyzer – a clinical evaluation study
  18. Evaluation of the ABX Pentra 400: a newly available clinical chemistry analyser
Heruntergeladen am 13.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2005.133/html
Button zum nach oben scrollen